Chan Lee
Vermögen: 20 Mio $ am 30.06.2026
Vermögen: 20 Mio $ am 30.06.2026
Chan Lee is currently Secretary, Senior Vice President & General Counsel at BeOne Medicines Ltd. since 2022.
Formerly, Mr. Lee was General Counsel-North America Specialty Care at Sanofi from 2016 to 2022 and Chief Counsel-Innovative Health at Pfizer Inc. in 2016.
Education includes undergraduate studies at Cornell University and graduate studies at the University of California, Berkeley.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 30.07.2026 | 325.312 ( 0,28 % ) | 12 Mio $ | 30.06.2026 | |
BEONE MEDICINES LTD. 0,02 % | 08.07.2026 | 338.884 ( 0,02 % ) | 7 Mio $ | 30.06.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| BEIGENE LTD | General Counsel | 18.07.2022 |
| Unternehmen | Position | Ende |
|---|---|---|
| SANOFI | Corporate Officer/Principal | 01.07.2022 |
| PFIZER INC. | Corporate Officer/Principal | 01.06.2016 |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 5 |
|---|---|
Pfizer Inc.
Pfizer Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients | Health Technology |
Sanofi
Sanofi Pharmaceuticals: MajorHealth Technology Engages in research, development and production of pharmaceuticals & vaccines | Health Technology |
Cornell University
Cornell University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of California, Berkeley
University of California, Berkeley Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
BeiGene Ltd.
BeiGene Ltd. Pharmaceuticals: MajorHealth Technology Develops biopharmaceutical products | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen